Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Reliq Health Technologies Inc V.RHT.H

Alternate Symbol(s):  RQHTF

Reliq Health Technologies Inc. is a global healthcare technology company that specializes in developing virtual care solutions for the healthcare market. The Company’s iUGO Care platform supports care coordination and community-based virtual healthcare. iUGO Care allows complex patients to receive care at home, improving health outcomes, enhancing quality of life for patients and families and reducing the cost of care delivery. iUGO Care provides real-time access to remote patient monitoring data, allowing for timely interventions by the care team to prevent hospital readmissions and ER visits. The iUGO Care platform integrates wearables, sensors, voice technology and mobile apps and desktop user interfaces for patients, clinicians and healthcare administrators. The iUGO Care platform provides services, such as remote patient monitoring, chronic care management, principal care management, behavioral health integration, telemedicine, transitional care management, wound care, and others.


TSXV:RHT.H - Post by User

Comment by Lifeboat1on Jan 06, 2023 11:50am
119 Views
Post# 35207030

RE:RE:RE:RE:RE:Contract Extension - diversification

RE:RE:RE:RE:RE:Contract Extension - diversification

ISFCA - Have you actually been following anything the Company says or done any DD.  

In addition to orthopedics the Company highlighted cardiology.

A significant percentage of Medicare patients have multiple comorbidities.  See below.  Knowledge is a wonderful thing.  

For Medicare patients treated by orthopaedic and neurosurgeons, the nationwide prevalence of ischemic heart disease, diabetes, depression, chronic kidney disease, and heart failure was 35%/39%, 31%/33%, 23%/31%, 19%/23%, and 17%/19%, respectively

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7677728/

<< Previous
Bullboard Posts
Next >>